Faika Mseeh
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Pancreatic function and diabetes, Diabetes Treatment and Management, Protein Tyrosine Phosphatases, Lung Cancer Treatments and Mutations, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Experimental Determination and System Level Analysis of Essential Genes in Escherichia coli MG1655(2003)727 cited
- → Lrp5 functions in bone to regulate bone mass(2011)449 cited
- → From Genetic Footprinting to Antimicrobial Drug Targets: Examples in Cofactor Biosynthetic Pathways(2002)279 cited
- → LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial(2012)237 cited
- → LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose(2013)181 cited
- → Improved glycemic control in mice lacking Sglt1 and Sglt2(2012)157 cited
- → Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib(2020)102 cited
- → Crystal Structure of Human Riboflavin Kinase Reveals a β Barrel Fold and a Novel Active Site Arch(2003)81 cited
- → Novel l-Xylose Derivatives as Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes(2009)76 cited
- → NOTUM inhibition increases endocortical bone formation and bone strength(2019)75 cited